ACCESSION: MSBNK-SMB_Measured-HSA001P0244002
RECORD_TITLE: Characterized; N-Undecanoylglycine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 25
COMMENT: RAW_SPEC {'9_posi_3908': {'bp': 3881670.0, 'sum': 5026895.0}, '18_posi_3951': {'bp': 3878480.0, 'sum': 4905578.0}, '10_posi_3908': {'bp': 3355299.0, 'sum': 4292267.0}, '17_posi_3910': {'bp': 2287962.0, 'sum': 3057770.0}, '7_posi_3910': {'bp': 1498701.0, 'sum': 1977240.0}, '13_posi_3932': {'bp': 1300953.0, 'sum': 1721353.0}, '14_posi_3911': {'bp': 1254944.0, 'sum': 1631515.0}, '5_posi_3891': {'bp': 1118246.0, 'sum': 1562112.0}, '2_posi_3890': {'bp': 1108092.0, 'sum': 1610070.0}, '3_posi_3912': {'bp': 1102421.0, 'sum': 1526348.0}, '1_posi_3890': {'bp': 1070210.0, 'sum': 1563200.0}, '17_posi_3971': {'bp': 1041606.0, 'sum': 1395951.0}, '8_posi_3894': {'bp': 938549.0, 'sum': 1260050.0}, '16_posi_3911': {'bp': 832202.0, 'sum': 1219001.0}, '1_posi_3830': {'bp': 661932.0, 'sum': 1078280.0}, '12_posi_3890': {'bp': 652637.0, 'sum': 956939.0}, 'ProcedureBlank_3848': {'bp': 598413.0, 'sum': 976249.0}, '13_posi_3872': {'bp': 555155.0, 'sum': 820185.0}, '15_posi_3891': {'bp': 430484.0, 'sum': 760595.0}, '6_posi_3930': {'bp': 368506.0, 'sum': 639946.0}, '4_posi_3915': {'bp': 355937.0, 'sum': 679181.0}, '15_posi_3955': {'bp': 239509.0, 'sum': 495327.0}, '19_posi_4020': {'bp': 217267.0, 'sum': 477290.0}, '12_posi_3950': {'bp': 205389.0, 'sum': 422972.0}, '18_posi_4013': {'bp': 192262.0, 'sum': 432131.0}}
COMMENT: RETENTION_TIME_STDEV 0.087
COMMENT: PRECURSOR_M/Z_RAW 244.190294
COMMENT: PRECURSOR_M/Z_STDEV 0.000060
COMMENT: PRECURSOR_IN_MS1 mz 244.190782; int 173.559; delta(ppm) 1.340950
COMMENT: PROPOSED_CHARGE_STATE +1; mz 245.194005; int 24.767; cor 0.974
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.210; C13H25NO3; [M+H]+; delta(ppm) 0.209718
COMMENT: PROPOSED_MF MS-FINDER 3.790; C13H25NO3; [M+H]+; delta(ppm) 0.208432
COMMENT: PROPOSED_MF SIRIUS5_Sirius 40.411; C13H25NO3; [M+H]+; delta(ppm) 0.208432
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C13H25NO3; [M+H]+; delta(ppm) 0.208432
COMMENT: PROPOSED_MF SIRIUS6_Sirius 56.333; C13H25NO3; [M+H]+; delta(ppm) 0.208432
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.933; C11H23N4O2; [M+H]+; delta(ppm) 5.706885
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C13H25NO3; [M+H]+; delta(ppm) 0.208432
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.358; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; OCC1(CNCC2CCCC2)CC(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.200; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; CCOC(=O)[C@@]1(CCCC[C@@]1(O)CC)N(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.100; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.051; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M+H]+; CCOC(=O)[C@@]1(O)CCCC[C@]1(CC)N(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CC(C)OC(=O)[C@H](O)[C@@H](N)CC1CCCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.911; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.788; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.745; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.641; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.458; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; UNPD49763
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.449; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M+H]+; UNPD186376
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; N-Undecanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.966; GSYSEQUYQXPNHH-WEUYFXHZNA-N; [M+H]+; CYCLOHEXYL-NORSTATINE
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.923; KWMRFDVSMVGRLI-UHFFFAOYSA-N; [M+H]+; 4-{[(cyclopentylmethyl)amino]methyl}-4-(hydroxymethyl)cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.915; WMCLKPGRHOQJAI-UHFFFAOYSA-N; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.875; PGJJWEQJZIWKQY-QWAQRTLVNA-N; [M+H]+; UNPD49763
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.870; BORDUPYPIRUXNW-NVHKGDCHNA-N; [M+H]+; UNPD186376
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.141; HEUQYIQQCNOXOG-UHFFFAOYSA-N; [M+H]+; 2-(undecanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.414; OXPWHPCCUXESFQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.534; YNBRORWNNGUYQA-NSHDSACASA-N; [M+H]+; tert-butyl N-[(1R)-1-cyclohexyl-2-hydroxyethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.518; DIQOZPGKFVICKN-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.495; NJXIJKXUFFXDMC-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(8-oxooctyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.470; ZLEBLWDLKHDYEW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(1-cyclopentyl-3-hydroxypropan-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.445; HLSJFBQWCBNSQQ-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-hydroxyethyl)-2,2-dimethylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.438; VCIBBCGSWUMTGW-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[[2-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.427; DBWREWKJBLECNR-MNOVXSKESA-N; [M+H]+; tert-butyl N-[[(1R,3S)-3-(hydroxymethyl)cyclohexyl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.420; ASVYJCJXBYNYKQ-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(5,5-dimethyl-1-oxohexan-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.124; YXZJRETWUVFEFX-ZJUUUORDSA-N; [M+H]+; tert-butyl (2S,4R)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; VXKVVXXJHGUYAQ-UHFFFAOYSA-N; [M+H]+; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; CSBKKQVPRRRVQQ-UHFFFAOYSA-N; [M+H]+; heptyl 2-(diethylamino)-2-oxoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.655; HEUQYIQQCNOXOG; [M+H]+; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.705; GSYSEQUYQXPNHH; [M+H]+; propan-2-yl 3-amino-4-cyclohexyl-2-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.121; SZUMGHGZFKDFPU; [M+H]+; 3-methyl-2-(octanoylamino)butanoic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.748; KWMRFDVSMVGRLI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.360; NJXIJKXUFFXDMC; [M+H]+; Carbamic acid, (8-oxooctyl)-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.954; OXPWHPCCUXESFQ; [M+H]+; Boc-4-Piperidinepropanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.528; ZZAPENIYDFOWME; [M+H]+; Ethyl N-(2,3-dimethyl-2-isopropyl-1-oxobutyl)glycinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.605; YNBRORWNNGUYQA; [M+H]+; N-Boc-D-cyclohexylglycinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.367; CSBKKQVPRRRVQQ; [M+H]+; Heptyl N,N-diethyloxamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.215; JTKDORYHWJDUAS; [M+H]+; 1-(4,4-Diethoxybutyl)piperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.399; WMCLKPGRHOQJAI; [M+H]+; N-(2,2-dimethyloxan-4-yl)-N-(3-hydroxypropyl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.438; VXKVVXXJHGUYAQ; [M+H]+; 6-[3-(2-ethoxyethoxy)propyl]-8-oxa-6-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -395.754; PGJJWEQJZIWKQY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -409.369; BORDUPYPIRUXNW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.648; HEUQYIQQCNOXOG; [M+H]+; acylglycine C:11
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.420; PXQZPBAIIXBGHU; [M+H]+; 13-Amino-6-oxotridecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.180; ZAZOBUILGRNKGF; [M+H]+; 13-Amino-8-oxotridecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.383; BDCYCGCYDCJCPF; [M+H]+; 6-Amino-2-[(1-hydroxycyclohexyl)methyl]hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.810; BSPCANZJQMZZGY; [M+H]+; 2-(3-Aminopropyl)-5-cyclopentyl-4-hydroxypentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.476; KAPFYXMKWYVRPQ; [M+H]+; 6-Amino-2-[3-(oxolan-2-yl)propyl]hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -176.056; IIDGBJOYKUNRBW; [M+H]+; 2-Acetyl-11-aminoundecanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -179.359; JJBXHSOWZFEVGZ; [M+H]+; 4-(3-Hydroxypropyl)-4-(2-isocyanoethyl)heptane-1,7-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.467; KEFPPVZKJYLFNT; [M+H]+; 8-Amino-2-pentanoyloctanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.097; YXUSYUJQDXDCGB; [M+H]+; 2-(Aminomethyl)-2-(cyclopropylmethyl)-8-hydroxyoctanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.430; QIUYPAWYPUCIDM; [M+H]+; 6-Amino-2-(2-hydroxycycloheptyl)hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.469; PXQZPBAIIXBGHU; [M+H]+; 13-Amino-6-oxotridecanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, N-Undecanoylglycine, HEUQYIQQCNOXOG-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (3), MS-FINDER:MsfinderDB (2), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0013286;
CH$NAME: N-Undecanoylglycine
CH$NAME: 2-(undecanoylamino)acetic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C13H25NO3
CH$EXACT_MASS: 243.183444
CH$SMILES: CCCCCCCCCCC(=O)NCC(=O)O
CH$IUPAC: InChI=1S/C13H25NO3/c1-2-3-4-5-6-7-8-9-10-12(15)14-11-13(16)17/h2-11H2,1H3,(H,14,15)(H,16,17)
CH$LINK: CHEBI CHEBI:74438
CH$LINK: HMDB HMDB0013286
CH$LINK: INCHIKEY HEUQYIQQCNOXOG-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:454092
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.848
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 244.190771
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-0190000000-2c50fa4c3e64d680be73
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  141.1021872 32.7380 141.102091 1.9631 27.35 -0.0278 25 ?
  142.1337887 10.8956 142.133692 1.8222 8.94 0.1455 19 ?
  163.1481777 20.4366 163.148067 2.1146 4.32 1.0000 24 f{C12H19}/0.31ppm,p-C1H7N1O3
  173.1326652 12.1585 173.132548 1.8194 5.90 0.8035 22 f{C13H17}/1.09ppm,p-H9N1O3
  180.1748311 36.8828 180.174710 1.5762 5.97 0.9513 25 f{C12H22N1}/0.86ppm,p-C1H4O3
  181.1588931 15.4166 181.158771 1.6891 3.85 0.9549 20 f{C12H21O1}/1.11ppm,p-C1H5N1O2
  198.1853641 22.6739 198.185231 1.1000 4.59 0.9447 23 f{C12H24N1O1}/0.62ppm,p-C1H2O2
  208.1695319 16.1550 208.169393 3.0504 4.50 0.9429 21 f{C13H22N1O1}/-0.28ppm,p-H4O2
  209.1535706 12.2670 209.153431 2.8878 8.07 0.6827 20 f{C13H21O2}/-0.17ppm,p-H5N1O1
  226.1805028 999.0000 226.180353 1.4988 0.00 0.9661 25 f{C13H24N1O2}/1.54ppm,p-H2O1
  227.1647243 10.2439 227.164574 3.0727 2.23 0.9509 19 f{C13H23O3}/2.44ppm,p-H3N1
  244.1297587 11.7901 244.129598 3.3753 13.00 0.0417 18 ?
  244.2128702 145.1115 244.212709 1.9450 121.59 -0.1104 25 ?
  244.2329962 22.2579 244.232835 1.5600 17.39 -0.1600 25 ?
  245.1749011 26.0904 245.174740 2.3249 3.61 0.9368 24 ?
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  141.102187 32.74 32
  142.133789 10.90 10
  163.148178 20.44 20
  173.132665 12.16 12
  180.174831 36.88 36
  181.158893 15.42 15
  198.185364 22.67 22
  208.169532 16.16 16
  209.153571 12.27 12
  226.180503 999.00 999
  227.164724 10.24 10
  244.129759 11.79 11
  244.212870 145.11 145
  244.232996 22.26 22
  245.174901 26.09 26
//
